Jacobs Levy Equity Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-116,249
Closed -$36.5M 1053
2025
Q2
$36.5M Sell
116,249
-5,215
-4% -$1.57M 0.14% 150
2025
Q1
$37M Buy
121,464
+105,807
+676% +$35.6M 0.15% 153
2024
Q4
$5.2M Buy
15,657
+14,537
+1,298% +$4.93M 0.02% 425
2024
Q3
$374K Buy
+1,120
New +$425K ﹤0.01% 865
2022
Q4
Sell
-287,194
Closed -$45.1M 996
2022
Q3
$45.1M Buy
287,194
+273,887
+2,058% +$43.7M 0.36% 72
2022
Q2
$1.99M Buy
+13,307
New +$1.93M 0.02% 600
2019
Q4
Sell
-9,776
Closed -$822K 1040
2019
Q3
$822K Sell
9,776
-16,640
-63% -$1.26M 0.01% 646
2019
Q2
$1.73M Sell
26,416
-4,880
-16% -$281K 0.02% 547
2019
Q1
$1.85M Sell
31,296
-68,031
-68% -$4.06M 0.03% 526
2018
Q4
$5.26M Buy
99,327
+4,520
+5% +$248K 0.09% 248
2018
Q3
$5.68M Sell
94,807
-15,805
-14% -$865K 0.08% 287
2018
Q2
$4.76M Buy
110,612
+79,636
+257% +$3.22M 0.07% 318
2018
Q1
$1.08M Buy
+30,976
New +$1.13M 0.02% 619

Other funds holding MEDP

Jacobs Levy Equity Management's MEDP Position: Q3 2025 in Review

Jacobs Levy Equity Management sold out of Medpace (MEDP) in Q3 2025, closing a stake of 116,249 shares — an estimated $36.5M sold.

Jacobs Levy Equity Management first reported a position in MEDP in Q1 2018 and held it in 13 quarters. The position peaked at $45.1M in Q3 2022. 672 funds tracked by Wall St. Rank hold MEDP as of Q3 2025.

  • Jacobs Levy Equity Management reported no remaining Medpace position as of Q3 2025 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 116,249 Medpace shares in Q3 2025, an estimated $36.5M.
  • Jacobs Levy Equity Management first reported a position in Medpace in Q1 2018 and held it in 13 quarters.
  • Jacobs Levy Equity Management's Medpace position peaked at $45.1M in Q3 2022.
  • 672 funds tracked by Wall St. Rank held Medpace as of Q3 2025.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2025, filed 17 Nov 2025.